Showing results (1311-1320 of 3,352) with videos related to
Sort By:
Pageof 336
Pharmacoeconomics|March 8, 2005
Cost-minimisation analysis of sivelestat for acute lung injury associated with systemic inflammatory response syndromeNaoki Aikawa, Seitaro Fujishima, Makoto Kobayashi, et al.Pharmacoeconomics|July 1, 2005
Price differentiation and transparency in the global pharmaceutical marketplaceDavid B RidleyPharmacoeconomics|February 28, 2004
Economic implications of attention-deficit hyperactivity disorder for healthcare systemsCynthia L Leibson, Kirsten Hall LongPharmacoeconomics|February 28, 2004
Development and validation of the Diabetic Foot Ulcer Scale-short form (DFS-SF)Carla M Bann, Sheri E Fehnel, Dennis D GagnonPharmacoeconomics|September 29, 2004
Does seropositivity for Helicobacter pylori antibodies increase outpatient costs for gastric and duodenal ulcer or inflammation?Akira Babazono, Motonobu Miyazaki, Hiroshi Une, et al.Pharmacoeconomics|September 29, 2004
Economic impact of migraine and other episodic headaches in France: data from the GRIM2000 studyAndré Pradalier, Jean-Paul Auray, Abdelkader El Hasnaoui, et al.Pharmacoeconomics|September 29, 2004
Comparisons of hypertension-related costs from multinational clinical studiesC Daniel Mullins, Mirko Sikirica, Viran Seneviratne, et al.Pharmacoeconomics|June 18, 2005
The economics of topical immunomodulators for the treatment of atopic dermatitisWilliam Abramovits, Mark Boguniewicz, Amy S Paller, et al.Pharmacoeconomics|July 29, 2018
Sacubitril/Valsartan (LCZ696): A Novel Treatment for Heart Failure and its Estimated Cost Effectiveness, Budget Impact, and Disease Burden Reduction in GermanyAfschin Gandjour, Dennis A OstwaldPageof 336